Jupiter Topco’s Ascendis Pharma A/S ASND Stock Holding History

Jupiter Topco’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$973M	Buy	+3,648,772	New	+$852M	0.4%	49

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jupiter Topco's ASND Position: Q2 2026 in Review

Jupiter Topco opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 3,648,772 shares worth $973M. The stake represents 0.4% of the portfolio and ranks #49 among its holdings.

286 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Jupiter Topco held 3,648,772 shares of Ascendis Pharma A/S worth $973M as of Q2 2026.
Ascendis Pharma A/S was a new Jupiter Topco position in Q2 2026.
Ascendis Pharma A/S made up 0.4% of Jupiter Topco's portfolio in Q2 2026, its #49 holding.
286 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.